This article relates to SDG 3. This resource, created together by Osmosis and the National Organization for Rare Diseases (NORD), aims to increase the knowledge and awareness about Leprosy, an ancient chronic infection disease that can affect the skin, eyes, and nervous system.
This article relates to SDG 3. This resource, created together by Osmosis and the National Organization for Rare Diseases (NORD), aims to increase the knowledge and awareness about Gorlin Syndrome, a mutation in a tumor suppressor gene is the root cause of proliferation of cancer cells, leading to basal cell carcinomas, abnormal cysts in the jaw, bone deformities, and several other manifestations.
This article analyses the practice of indigenous conflict resolution mechanisms in building a culture of peace in Ethiopia.
This study investigates three Mediterranean coastal lagoons to study harmful algae and pathogens on plastic debris.
This chapter advances UN SGD goal 2: Zero Hunger by providing insight into adapting agriculture to changing climate conditions.
Looking at creative arts therapy to alleviate burnout among healthcare professionals.
One Health and the Exposome embrace a broad view of human health and its environmental drivers as well as provide various tools and modes of operation to systematically uncover pathways linking poor health outcomes with their root causes to inform interventions supporting the WHO SDG3.
Habitat conversion and resource utilization have been identified in the One Health approach as drivers of poor ecosystem health that can lead to disease spillover events supporting SDG3.
Elsevier,
Principles of Gender-Specific Medicine (Fourth Edition)
Sex and Gender-Specific Biology in the Postgenomic Era
2023, Pages 409-429
This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reduced Inequalities by emphasizing the importance of gender-specific medicine in pharmaceutical development and global healthcare, aiming to improve health outcomes for all genders. By addressing the challenges faced by the pharmaceutical industry in integrating knowledge on sex-specific biological differences into drug development programs, the chapter advocates for strategies to promote equity in healthcare access and outcomes. Additionally, it recognizes the importance of addressing gender disparities in healthcare and advocating for approaches that ensure equal access to gender-specific pharmaceuticals. Through these efforts, the content supports the goal of reducing inequalities in healthcare access and outcomes, ultimately contributing to the promotion of good health and well-being for all individuals, regardless of gender.
Functionalized Nanofibers - Chapter 32: Environmental impact and safety of functionalized nanofibers
Functionalized Nanofibers: Synthesis and Industrial Applications, 2023, Pages 923-943
This chapter aligns with Goals 12 and 13 by reviewing the potential pathways of nanofibers’ release to the environment and discussing the impact of various types of nanofibers on human and animal health.
